Targeted Next-Generation Sequencing of Cell-Free DNA to Detect MYC-Immunoglobulin Translocation and Epstein-Barr Virus DNA in Plasma of Burkitt Lymphoma Patients in East Africa The following ...
Researchers have uncovered the mechanisms behind three unique subtypes of mismatch repair deficient high-grade gliomas. The findings provide a clearer understanding of how these tumors develop, ...
The initial idea behind the study came from patients with rectal cancer, and we saw that a proportion of patients with mismatch repair deficient (MMRd) tumors did not do well with standard therapy ...
NSABP FC-13 (EMPIRE): A phase II platform study of cemiplimab monotherapy or cemiplimab-based combinations in patients with colorectal cancer and minimal residual disease (MRD) after definitive ...
The Dako Omnis test identifies mismatch repair deficient colorectal cancer patients eligible for Opdivo or Opdivo plus Yervoy treatment. Mismatch repair deficiency results in DNA replication errors, ...
L1, EBV and mismatch repair deficiency suggests CLDN18.2 stratification must be integrated into multi-biomarker algorithms rather than used in isolation. Treatment interactions emerged: CLDN18.2-high ...
Breakfast to benefit Teal Esmeyer. When: 8-11 a.m., March 28. Where: Gene Autry Catoosa Masonic Lodge, 109 E. Denbo St. in ...
Morning Overview on MSN
Study links an ALS-related protein to DNA repair, cancer, and dementia risk
A protein long studied for its role in amyotrophic lateral sclerosis and frontotemporal dementia now appears to serve a second, equally critical function, safeguarding the integrity of human DNA.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results